# Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)

> **NCT01336543** · PHASE2 · WITHDRAWN · sponsor: **Syed Jafri**

## Conditions studied

- Stage III Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Chemotherapy following concurrent Chemoradiotherapy

## Key facts

- **NCT ID:** NCT01336543
- **Lead sponsor:** Syed Jafri
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-03
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Low accrual, small patient population at center.
- **Last updated:** 2014-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336543, "Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01336543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*